Refresh

Suven Pharmaceuticals Ltd - Receipt Of Observation Letter With 'No Adverse Observations' From BSE Limited And 'No Objection' From The National Stock Exchange Of India Limited For The Scheme Of Amalgamation


Download
23 Jul 2024
Receipt of Observation letter with "no adverse observations" from BSE and "no objection" from NSE for the scheme of amalgamation

Source: BSE India

View all announcements for Suven Pharmaceuticals Ltd
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com